XML 49 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value (Tables)
9 Months Ended
Feb. 28, 2019
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

At February 28, 2019, our assets and liabilities measured at fair value on a recurring basis were as follows:

 

 

 

 

 

 

 

Significant

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

Other

 

 

Significant

 

 

 

 

 

 

 

in Active

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Markets

 

 

Inputs

 

 

Inputs

 

 

 

 

 

(in thousands)

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Totals

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (1)

 

$

-

 

 

$

926

 

 

$

-

 

 

$

926

 

Total assets

 

$

-

 

 

$

926

 

 

$

-

 

 

$

926

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (1)

 

$

-

 

 

$

2,627

 

 

$

-

 

 

$

2,627

 

Total liabilities

 

$

-

 

 

$

2,627

 

 

$

-

 

 

$

2,627

 

 

At May 31, 2018, our assets and liabilities measured at fair value on a recurring basis were as follows:

 

 

 

 

 

 

 

Significant

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

Other

 

 

Significant

 

 

 

 

 

 

 

in Active

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Markets

 

 

Inputs

 

 

Inputs

 

 

 

 

 

(in thousands)

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Totals

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (1)

 

$

-

 

 

$

11,423

 

 

$

-

 

 

$

11,423

 

Total assets

 

$

-

 

 

$

11,423

 

 

$

-

 

 

$

11,423

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (1)

 

$

-

 

 

$

846

 

 

$

-

 

 

$

846

 

Total liabilities

 

$

-

 

 

$

846

 

 

$

-

 

 

$

846

 

 

 

(1)

The fair value of our derivative instruments is based on the present value of the expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities.  Market observable, Level 2 inputs are used to determine the present value of the expected future cash flows.  Refer to “NOTE O – Derivative Instruments and Hedging Activities” for additional information regarding our use of derivative instruments.

Assets Measured at Fair Value on Non-Recurring Basis

At May 31, 2018, our assets measured at fair value on a non-recurring basis were as follows:

 

 

 

 

 

 

 

Significant

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

Other

 

 

Significant

 

 

 

 

 

 

 

in Active

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Markets

 

 

Inputs

 

 

Inputs

 

 

 

 

 

(in thousands)

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Totals

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-lived assets held for sale (1)

 

$

-

 

 

$

30,000

 

 

$

-

 

 

$

30,000

 

Total assets

 

$

-

 

 

$

30,000

 

 

$

-

 

 

$

30,000

 

 

 

 

1)

During the fourth quarter of fiscal 2018, management committed to a plan to sell the Company’s cryogenics business in Turkey, Worthington Aritas, and certain underperforming oil & gas equipment assets within Pressure Cylinders. In accordance with the applicable accounting guidance, the net assets in each asset group were recorded at the lower of net book value or fair value less costs to sell.  The book value of Worthington Aritas exceeded its fair market value of $9,000,000, resulting in an impairment charge of $42,422,000.  The book value of the oil & gas equipment asset group also exceeded its estimated fair market value of $21,000,000, resulting in an impairment charge of $10,497,000.

 

During the first quarter of fiscal 2019, the Company completed the sale of the oil & gas equipment assets described above.  In addition, the Company lowered its estimate of the fair value of Worthington Aritas to $7,000,000, resulting in an impairment charge of $2,381,000.